- Home
- AURA vs MTLS Comparison
AURA vs MTLS Comparison
Compare AURA & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AURA
- MTLS
- Stock Information
- Founded
- AURA 2007
- MTLS 1990
- Country
- AURA United States
- MTLS Belgium
- Employees
- AURA N/A
- MTLS N/A
- Industry
- AURA Biotechnology: Pharmaceutical Preparations
- MTLS Computer Software: Prepackaged Software
- Sector
- AURA Health Care
- MTLS Technology
- Exchange
- AURA Nasdaq
- MTLS Nasdaq
- Market Cap
- AURA 396.8M
- MTLS 349.7M
- IPO Year
- AURA 2021
- MTLS 2014
- Fundamental
- Price
- AURA $6.01
- MTLS $6.15
- Analyst Decision
- AURA Strong Buy
- MTLS
- Analyst Count
- AURA 7
- MTLS 0
- Target Price
- AURA $22.29
- MTLS N/A
- AVG Volume (30 Days)
- AURA 283.0K
- MTLS 146.7K
- Earning Date
- AURA 11-11-2025
- MTLS 10-23-2025
- Dividend Yield
- AURA N/A
- MTLS N/A
- EPS Growth
- AURA N/A
- MTLS N/A
- EPS
- AURA N/A
- MTLS 0.11
- Revenue
- AURA N/A
- MTLS $311,850,851.00
- Revenue This Year
- AURA N/A
- MTLS $2.98
- Revenue Next Year
- AURA N/A
- MTLS $7.09
- P/E Ratio
- AURA N/A
- MTLS $60.22
- Revenue Growth
- AURA N/A
- MTLS 2.98
- 52 Week Low
- AURA $4.35
- MTLS $3.93
- 52 Week High
- AURA $12.38
- MTLS $9.69
- Technical
- Relative Strength Index (RSI)
- AURA 35.91
- MTLS 64.80
- Support Level
- AURA $5.93
- MTLS $6.10
- Resistance Level
- AURA $6.28
- MTLS $6.41
- Average True Range (ATR)
- AURA 0.25
- MTLS 0.29
- MACD
- AURA -0.03
- MTLS 0.08
- Stochastic Oscillator
- AURA 0.00
- MTLS 83.05
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.